🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these profiles privately for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering products of uncertain source.

Several professionals stated the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or prison.

Platform Response and Content Elimination

According to the social media company, the service has removed problematic content and banned associated hashtags and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in strengthening compliance measures.

Online Trading Activities

Research also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, populated with photos of slimming results, glowing testimonials and detailed instructions for preparing or injecting at residence.

Within moments of joining one group, a vendor shared contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Product Information and Pricing

Inside these communities, posts show black plastic packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant health risks”.